The Core Difference in One Number
On Aave V3 Arbitrum, you can borrow up to 73% of your WBTC value (LTV). On Morpho Blue, the same WBTC gets you up to 86% LLTV. That 13-point gap is not minor — on a $100,000 BTC position, it's $13,000 more borrowing capacity. The question is whether that extra room is worth the tradeoffs.
Parameters Side by Side (June 2026)
| Aave V3 (Arbitrum) | Morpho Blue | |
|---|---|---|
| WBTC Max LTV / LLTV | 73% | 86% |
| ETH Max LTV / LLTV | 80% | 86% |
| wstETH Max LTV / LLTV | 75% | 94.5% |
| WBTC Borrow APY | ~6.5% | ~5.4% |
| ETH Borrow APY | ~5.3% | ~4.5% |
| WBTC Liquidation Penalty | 10% | 8% |
| Multi-collateral | Yes | No (isolated pairs) |
| Variable rate risk | Yes | Yes |
| Governance / upgradeable | Yes (DAO) | No (immutable) |
Source: Aave V3 and Morpho Blue protocol interfaces, June 2026. Rates are variable and change daily.
When Aave V3 Wins
Multi-collateral positions. Aave lets you deposit WBTC + ETH + stablecoins as collateral simultaneously. Morpho Blue is isolated — each market is one collateral against one borrow asset. If your portfolio is diversified, Aave's aggregation makes managing a single position simpler.
Ecosystem depth. Aave V3 has been audited extensively and has more liquidity. For very large positions (>$1M), liquidation risk in thin Morpho markets is a real concern.
When Morpho Blue Wins
Pure leverage loops. If your strategy is to borrow stablecoins against a single asset and re-deposit, Morpho's higher LLTV lets you run more loops before hitting the cap. A WBTC→USDC loop on Morpho at 86% can achieve ~7× leverage; on Aave at 73%, you cap at ~3.7×.
wstETH strategy. The wstETH/WETH market on Morpho has a 94.5% LLTV. Since wstETH and ETH are highly correlated, the liquidation risk at high LTV is very low. This is the most capital-efficient way to earn staking yield while borrowing ETH.
Morpho Blue wins on pure capital efficiency (higher LLTV, lower liquidation penalty, lower rates). Aave V3 wins on flexibility (multi-collateral, larger ecosystem, simpler UX for diverse portfolios). For a BTC maximalist running a leverage loop, Morpho is the better tool. For someone managing a mixed portfolio of crypto assets, Aave is safer and simpler.
The Health Factor Difference
This is where things get subtle. Morpho's higher LLTV means you can borrow more — but if you actually use that capacity, your health factor is lower, meaning you're closer to liquidation. The choice is not "more borrowing power = safer". It's "more borrowing power = more responsibility to manage."
Example: $100,000 WBTC, borrowing $60,000 USDC. On Aave V3 (Arbitrum), your health factor is approximately 78,000 / 60,000 = 1.30. On Morpho Blue, it's 86,000 / 60,000 = 1.43. Same borrow, same collateral — Morpho gives you a higher health factor. The protocol's higher LT is actually protecting you more at the same utilization.
Calculate your exact health factor, liquidation price and annual borrow cost on both protocols with your own numbers.
⚖️ Open Protocol Comparator →Key Risks to Know
Morpho market risk: Each Morpho market is curated independently. A WBTC/USDC market with low liquidity can make liquidations slow — good for borrowers in flash crashes, bad if you need to repay quickly. Always check the total liquidity of the specific market before opening a large position.
Aave rate spikes: Aave's variable rate is governed by a utilization model. When utilization exceeds the "kink" (usually 80-90%), rates can spike from 5% to 100%+ overnight. Always keep a reserve to repay or have alerts set.